Navigation Links
Accelr8 Announces Results of 2012 Annual Meeting
Date:12/13/2012

DENVER, Dec. 13, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) announced today the results of its 2012 Annual Meeting of Shareholders, which was held on Wednesday, December 12, 2012.  At the Annual Meeting, shareholders re-elected Lawrence Mehren, John Patience, Jack Schuler and Matthew Strobeck, Ph.D. as directors of the Company.  Proposals to reincorporate the Company in Delaware, change the Company's name to "Accelerate Diagnostics, Inc.", approve a new Certificate of Incorporation, approve a new Omnibus Equity Incentive Plan, and ratify the selection of Comiskey & Company, P.C. as the Company's independent auditors for the upcoming fiscal year were also approved by shareholders.

The Company plans to file documents with the Delaware and Colorado Secretaries of State to complete the reincorporation in Delaware and the name change described above as soon as possible. 

For more information about the proposals that were approved by the Company's shareholders at the Annual Meeting, refer to the Definitive Proxy Statement that the Company filed with the Securities and Exchange Commission on November 13, 2012, which is available at www.sec.gov.

About Accelr8
Accelr8 Technology Corporation is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.  The Company's BACcel™ platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that decrease time to result while maintaining high sensitivity and specificity. 

Disclaimer Regarding Forward-Looking Statements
Certain statements in this news release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Ex
'/>"/>

SOURCE Accelr8 Technology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product Development Continues with Launch Expected in 2015
2. Accelr8 Appoints Steve Reichling Chief Financial Officer
3. OncoSec Medical Announces $7.2 Million Public Offering
4. Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP
5. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
6. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
7. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
8. Mylan Announces Pricing of Senior Notes
9. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
10. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
11. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... Arias, M.D., Ph.D., at The University of Texas Health ... superbug that caused a bloodstream infection in a Brazilian ... of The New England Journal of Medicine . ... of highly-resistant bacteria known as methicillin-resistant Staphylococcus aureus ... hospital and community-associated infections. The superbug has also acquired ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2
... , , SAN DIEGO, ... reported financial results for the second quarter of 2009, including non-GAAP ... (STD), clinical diagnostics and total product sales. , , ... as a good performance from our core STD franchise, the inclusion ...
... , WASHINGTON, JULY 30 An estimated 4.1 million ... a House health reform bill, according to state-specific analysis of ... week by The Heritage Foundation . , ... a highly respected health care policy and management consulting firm, to examine ...
... expert says, might help keep elderly out of hospitals ... designed to increase muscle density in the elderly could ... suggests. , The contention stems from a study of ... about a five-year span, more than 55 percent of ...
... , , DALLAS , July ... provider of Internet-based claims processing solutions for the healthcare industry, today reported ... 2009. , , For the quarter ended June ... the $529,000 reported for the second quarter of 2008. Revenues for ...
... , , DALLAS, July 30 When ... Research Institute of Texas (CPRIT), they took a major step forward in ... $3 billion fund investing in cutting-edge, Texas-based research and commercialization projects aimed ... is a privilege for me to be part of CPRIT and to ...
... ... asthma patients to get a swine (H1N1) flu shot in addition to a seasonal flu ... for Disease Control and Prevention,s Vaccine Advisory Committee recommendations July 29 that identified people with ... ...
Cached Medicine News:Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 2Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 3Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 4Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 5Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 6Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 7Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 8Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 9Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 10Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 11Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 12Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 13Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 14Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 15Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 16Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 17Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 18Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 19Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 20Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 21Health News:Gen-Probe Reports Financial Results for Second Quarter 2009 22Health News:Millions of Pennsylvanians Could Lose Private Insurance, Study Shows 2Health News:Muscle Density Linked to Disability 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 2Health News:Claimsnet.com Reports Second Quarter 2009 Results 3Health News:Claimsnet.com Reports Second Quarter 2009 Results 4Health News:Texas on Top of Cancer Research: Dallas Regional Chamber Hosts Forum on New $3 Billion Fund 2Health News:Allergists Urge Asthmatics to Get Swine and Seasonal Flu Shots Following CDC Vaccine Advisory Committee Recommendations 2
XL STABI Hydrophilic Acrylic Lens....
XL OCTO Hydrophilic Acrylic Lens....
One piece multifocal acrylic intraocular lens....
MemoryLens Prefolded Acrylic Lens....
Medicine Products: